Skip to Navigation
Universities Allied for Essential Medicines
Our drugs. Our labs. Our responsibility.
Login
|
Register
Search mysite.com:
Our issues
Overview
Background: medical R&D
Background: patents
The research gap
The access gap
Bibliography
Glossary
Learn more
Our work
Proposals and projects
University tech transfer
Global access licensing
Technology transfer metrics
UC campaign
Neglected disease research
Overview
ND-Innovation Symposium
Patent pools
National legislation
USA
Canada
Bayh-Dole Act analogues
Take Action
International agreements
Student empowerment
Successes
Publications
Documents
FAQ
Get involved
Add your voice (PCS)
Jobs and Internships
Annual conference
2011: JHU & UMBC
Registration
2010: UNC & Duke
2009: Yale
2008: Berkeley
2007: Harvard
2006: Pennsylvania
Global Access to Medicines Month
Mailing list
Academic network
Alumni network
Buy a T-shirt
About us
Vision, mission, values
History
Student leaders
Board of Directors
Advisory Board
Our supporters
Contact us
Chapters
Find your local chapter
About starting a chapter
Register a chapter
Outreach coordinators
Resources
Event Report
Annual chapter update
News
Archive
Events
Newsletter
Blog
Media coverage
DONATE
Document archive
Home
› Summary of EA Case Studies
Summary of EA Case Studies
Submitted by atsallas on Fri, 09/11/2009 - 15:04
in
Case Studies
Handouts
Licensing
PCS
Stanford White Paper
TRIPS
WHO
Keyword(s):
Case Studies
,
Handouts
,
Licensing
,
PCS
,
Stanford White Paper
,
TRIPS
,
WHO
Author(s):
Universities Allied for Essential Medicines
Document Description / Abstract:
A summary of selected case studies and proposals by Yale, Berkeley, and Washington Universities.
Download File(s):
Summary of EA case studies.doc
Get connected
Donate now to support our work
